Dr. Reddy’s subsidiary Aurigene signs $438m licensing deal with Olema
Dr. Reddy’s Laboratories said that its fully-owned subsidiary Aurigene Discovery Technologies has signed an exclusive global collaboration and license agreement worth up to $438 million with US-based Olema Pharmaceuticals to discover and develop novel cancer therapies. Olema Pharmaceuticals and Aurigene Discovery Technologies will develop novel small molecule inhibitors of an undisclosed oncology target. Under the […]